KCF-S cluster No. 271 (25 metabolites)
Corresponding Phytochemical cluster No. 4
Plant Species
Cumulative plant class count
| class name | count |
|---|---|
| Liliopsida | 2 |
| asterids | 1 |
Cumulative family count
| class name | count |
|---|---|
| Clavicipitaceae | 31 |
| Amaryllidaceae | 1 |
| Convolvulaceae | 1 |
| Poaceae | 1 |
KEGG BRITE br08003
Categories (1)
| br08003 Category | # of metabolite |
|---|---|
| Indole alkaloids | 4 |
metabolites link (4)
| br08003 Category | KEGG ID | KNApSAcK ID |
|---|---|---|
| Indole alkaloids | C09162 | C00001719 |
| Indole alkaloids | C09164 | C00001720 |
| Indole alkaloids | C07545 | C00001721 |
| Indole alkaloids | C07544 | C00001724 |
Metabolite list (25)
| KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
figure |
|---|---|---|---|---|---|---|
|
C00001719
|
Ergocornine
|
CHEMBL1184281
CHEMBL1385840 CHEMBL1533896 CHEMBL1553665 CHEMBL1592382 CHEMBL1972911 |
C100271
|
120 / 72 / 63 |
|
|
|
C00001720
|
Ergocristine
|
CHEMBL446315
CHEMBL1433680 CHEMBL1440256 CHEMBL1486540 |
C100270
|
27 / 32 / 30 | 1 / 0 |
|
|
C00001721
|
alpha-Ergocryptine
|
CHEMBL1324934
CHEMBL1355095 CHEMBL1361596 CHEMBL1403281 |
C100269
|
42 / 37 / 38 | 1 / 0 |
|
|
C00001723
|
Ergosine
|
C030041
|
1 / 0 |
|
||
|
C00001724
|
Ergotamine
|
CHEMBL442
CHEMBL1315610 CHEMBL1402957 CHEMBL1982133 |
D004878
|
116 / 57 / 51 | 2 / 73 |
|
|
C00011222
|
Ergotaminine
|
CHEMBL442
CHEMBL1315610 CHEMBL1402957 CHEMBL1982133 |
116 / 57 / 51 |
|
||
|
C00011223
|
8-Hydroxyergotamine
|
|
||||
|
C00011224
|
Ergosinine
/ Ergoclavinine |
|
||||
|
C00011225
|
Ergostine
|
C030479
|
|
|||
|
C00011226
|
Ergostinine
|
|
||||
|
C00011227
|
Ergonine
|
|
||||
|
C00011228
|
Ergovaline
|
C076760
|
|
|||
|
C00011229
|
Ergoptine
|
C015858
|
|
|||
|
C00011230
|
Ergocorninine
|
CHEMBL1184281
CHEMBL1385840 CHEMBL1533896 CHEMBL1553665 CHEMBL1592382 CHEMBL1972911 |
120 / 72 / 63 |
|
||
|
C00011231
|
O-12'-Methylergocornine
|
|
||||
|
C00011232
|
Ergocristinine
|
CHEMBL446315
CHEMBL1433680 CHEMBL1440256 CHEMBL1486540 |
27 / 32 / 30 |
|
||
|
C00011235
|
O-12'-Methyl-alpha-ergokryptine
|
|
||||
|
C00011236
|
beta-Ergocryptine
|
|
||||
|
C00011237
|
5'-epi-beta-Ergocryptine
|
|
||||
|
C00011238
|
beta-Ergocryptam
|
|
||||
|
C00011239
|
beta,beta-Ergoannam
|
|
||||
|
C00011240
|
Ergobutine
|
|
||||
|
C00011241
|
Ergobutyrine
|
|
||||
|
C00026552
|
8-Hydroxy-alpha-ergokryptine
/ 8-alpha-Hydroxy-alpha-ergokryptine |
|
||||
|
C00039138
|
Ergocristam
|
|
Human Protein / Gene in interactions
139 ChEMBL Protein in interactions
| accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
|---|---|---|---|---|
| P55210 | Caspase-7 | C14 | C00001719 C00001720 C00001721 C00001724 C00011222 C00011230 C00011232 | 0 / 0 |
| P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00001719 C00001720 C00001721 C00001724 C00011222 C00011230 C00011232 | 1 / 1 |
| Q01196 | Runt-related transcription factor 1 | Unclassified protein | C00001719 C00001720 C00001721 C00001724 C00011222 C00011230 C00011232 | 1 / 4 |
| Q13951 | Core-binding factor subunit beta | Unclassified protein | C00001719 C00001720 C00001721 C00001724 C00011222 C00011230 C00011232 | 0 / 1 |
| O00255 | Menin | Unclassified protein | C00001719 C00001720 C00001721 C00001724 C00011222 C00011230 C00011232 | 2 / 5 |
| P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00001719 C00001720 C00001721 C00001724 C00011222 C00011230 C00011232 | 0 / 1 |
| P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00001719 C00001720 C00001721 C00001724 C00011222 C00011230 C00011232 | 0 / 1 |
| Q99714 | 3-hydroxyacyl-CoA dehydrogenase type-2 | Enzyme | C00001719 C00001720 C00001721 C00001724 C00011222 C00011230 C00011232 | 3 / 3 |
| P00352 | Retinal dehydrogenase 1 | Enzyme | C00001719 C00001720 C00001721 C00001724 C00011222 C00011230 C00011232 | 0 / 0 |
| P08183 | Multidrug resistance protein 1 | drug | C00001719 C00001720 C00001721 C00001724 C00011222 C00011230 C00011232 | 1 / 0 |
| P27695 | DNA-(apurinic or apyrimidinic site) lyase | Enzyme | C00001719 C00001720 C00001721 C00001724 C00011222 C00011230 C00011232 | 0 / 0 |
| Q9UBT6 | DNA polymerase kappa | Enzyme | C00001719 C00001720 C00001721 C00001724 C00011222 C00011230 C00011232 | 0 / 0 |
| P10636 | Microtubule-associated protein tau | Unclassified protein | C00001719 C00001720 C00001721 C00001724 C00011222 C00011230 C00011232 | 4 / 3 |
| B2RXH2 | Lysine-specific demethylase 4E | Enzyme | C00001719 C00001720 C00001721 C00001724 C00011222 C00011230 C00011232 | 0 / 0 |
| Q16665 | Hypoxia-inducible factor 1-alpha | Transcription Factor | C00001719 C00001720 C00001721 C00001724 C00011222 C00011230 C00011232 | 0 / 0 |
| P29466 | Caspase-1 | C14 | C00001719 C00001720 C00001721 C00001724 C00011222 C00011230 C00011232 | 0 / 0 |
| Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | C00001719 C00001720 C00001721 C00001724 C00011222 C00011230 C00011232 | 1 / 2 |
| O75496 | Geminin | Unclassified protein | C00001719 C00001720 C00001721 C00011230 C00011232 | 0 / 0 |
| P46063 | ATP-dependent DNA helicase Q1 | Enzyme | C00001719 C00001721 C00001724 C00011222 C00011230 | 0 / 0 |
| Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | C00001719 C00001720 C00001721 C00011230 C00011232 | 0 / 0 |
| Q9HC16 | DNA dC->dU-editing enzyme APOBEC-3G | Enzyme | C00001719 C00001721 C00001724 C00011222 C00011230 | 0 / 0 |
| P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00001719 C00001721 C00001724 C00011222 C00011230 | 0 / 0 |
| P11473 | Vitamin D3 receptor | NR1I1 | C00001719 C00001721 C00001724 C00011222 C00011230 | 2 / 3 |
| Q9NR56 | Muscleblind-like protein 1 | Unclassified protein | C00001719 C00001720 C00001721 C00011230 C00011232 | 1 / 0 |
| P15428 | 15-hydroxyprostaglandin dehydrogenase [NAD(+)] | Enzyme | C00001719 C00001720 C00001721 C00011230 C00011232 | 2 / 2 |
| P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00001719 C00001721 C00001724 C00011222 C00011230 | 1 / 0 |
| P21397 | Amine oxidase [flavin-containing] A | Oxidoreductase | C00001719 C00001724 C00011222 C00011230 | 1 / 1 |
| P25021 | Histamine H2 receptor | Histamine receptor | C00001719 C00001724 C00011222 C00011230 | 0 / 0 |
| P24557 | Thromboxane-A synthase | Cytochrome P450 5A1 | C00001719 C00001724 C00011222 C00011230 | 1 / 1 |
| P35367 | Histamine H1 receptor | Histamine receptor | C00001719 C00001724 C00011222 C00011230 | 0 / 0 |
| Q01959 | Sodium-dependent dopamine transporter | Dopamine | C00001719 C00001724 C00011222 C00011230 | 1 / 0 |
| P08912 | Muscarinic acetylcholine receptor M5 | Acetylcholine receptor | C00001719 C00001724 C00011222 C00011230 | 0 / 0 |
| P18825 | Alpha-2C adrenergic receptor | Adrenergic receptor | C00001719 C00001724 C00011222 C00011230 | 0 / 0 |
| P13945 | Beta-3 adrenergic receptor | Adrenergic receptor | C00001719 C00001724 C00011222 C00011230 | 0 / 0 |
| P18089 | Alpha-2B adrenergic receptor | Adrenergic receptor | C00001719 C00001724 C00011222 C00011230 | 0 / 0 |
| P07550 | Beta-2 adrenergic receptor | Adrenergic receptor | C00001719 C00001724 C00011222 C00011230 | 0 / 1 |
| P25024 | C-X-C chemokine receptor type 1 | CXC chemokine receptor | C00001719 C00001724 C00011222 C00011230 | 0 / 0 |
| P06241 | Tyrosine-protein kinase Fyn | Src | C00001719 C00001724 C00011222 C00011230 | 0 / 0 |
| Q08209 | Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | Ser_Thr | C00001719 C00001724 C00011222 C00011230 | 0 / 0 |
| P00918 | Carbonic anhydrase 2 | Lyase | C00001719 C00001724 C00011222 C00011230 | 1 / 2 |
| P10828 | Thyroid hormone receptor beta | NR1A2 | C00001720 C00001724 C00011222 C00011232 | 3 / 1 |
| P00533 | Epidermal growth factor receptor | TK tyrosine-protein kinase EGFR subfamily | C00001719 C00001724 C00011222 C00011230 | 1 / 8 |
| P06239 | Tyrosine-protein kinase Lck | Src | C00001719 C00001724 C00011222 C00011230 | 0 / 1 |
| P14416 | D(2) dopamine receptor | Dopamine receptor | C00001719 C00001724 C00011222 C00011230 | 2 / 0 |
| P23219 | Prostaglandin G/H synthase 1 | Oxidoreductase | C00001719 C00001724 C00011222 C00011230 | 0 / 0 |
| P37288 | Vasopressin V1a receptor | Vasopressin and oxytocin receptor | C00001719 C00001724 C00011222 C00011230 | 0 / 0 |
| P41145 | Kappa-type opioid receptor | Opioid receptor | C00001719 C00001724 C00011222 C00011230 | 0 / 0 |
| Q9Y271 | Cysteinyl leukotriene receptor 1 | Leukotriene receptor | C00001719 C00001724 C00011222 C00011230 | 0 / 0 |
| P29274 | Adenosine receptor A2a | Adenosine receptor | C00001719 C00001724 C00011222 C00011230 | 0 / 0 |
| P25929 | Neuropeptide Y receptor type 1 | Neuropeptide Y receptor | C00001719 C00001724 C00011222 C00011230 | 0 / 0 |
| P50052 | Type-2 angiotensin II receptor | Angiotensin receptor | C00001719 C00001724 C00011222 C00011230 | 1 / 1 |
| P17948 | Vascular endothelial growth factor receptor 1 | Vegfr | C00001719 C00001724 C00011222 C00011230 | 0 / 0 |
| P41968 | Melanocortin receptor 3 | Melanocortin receptor | C00001719 C00001724 C00011222 C00011230 | 1 / 0 |
| P25025 | C-X-C chemokine receptor type 2 | CXC chemokine receptor | C00001719 C00001724 C00011222 C00011230 | 0 / 0 |
| P30542 | Adenosine receptor A1 | Adenosine receptor | C00001719 C00001724 C00011222 C00011230 | 0 / 0 |
| P11509 | Cytochrome P450 2A6 | Cytochrome P450 2A6 | C00001719 C00001724 C00011222 C00011230 | 0 / 0 |
| P14780 | Matrix metalloproteinase-9 | M10A | C00001719 C00001724 C00011222 C00011230 | 2 / 2 |
| P25100 | Alpha-1D adrenergic receptor | Adrenergic receptor | C00001719 C00001724 C00011222 C00011230 | 0 / 0 |
| P23975 | Sodium-dependent noradrenaline transporter | Norepinephrine | C00001719 C00001724 C00011222 C00011230 | 1 / 1 |
| P27361 | Mitogen-activated protein kinase 3 | Erk | C00001719 C00001724 C00011222 C00011230 | 0 / 0 |
| P17252 | Protein kinase C alpha type | Alpha | C00001719 C00001724 C00011222 C00011230 | 0 / 0 |
| P04035 | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Oxidoreductase | C00001719 C00001724 C00011222 C00011230 | 0 / 0 |
| P08913 | Alpha-2A adrenergic receptor | Adrenergic receptor | C00001719 C00001724 C00011222 C00011230 | 0 / 0 |
| P21917 | D(4) dopamine receptor | Dopamine receptor | C00001719 C00001724 C00011222 C00011230 | 0 / 0 |
| P30988 | Calcitonin receptor | Calcitonin receptor | C00001719 C00001724 C00011222 C00011230 | 0 / 0 |
| P35462 | D(3) dopamine receptor | Dopamine receptor | C00001719 C00001724 C00011222 C00011230 | 1 / 0 |
| P41143 | Delta-type opioid receptor | Opioid receptor | C00001719 C00001724 C00011222 C00011230 | 0 / 0 |
| Q92731 | Estrogen receptor beta | NR3A2 | C00001719 C00001724 C00011222 C00011230 | 0 / 1 |
| P41595 | 5-hydroxytryptamine receptor 2B | Serotonin receptor | C00001719 C00001724 C00011222 C00011230 | 0 / 0 |
| P25101 | Endothelin-1 receptor | Endothelin receptor | C00001719 C00001724 C00011222 C00011230 | 0 / 0 |
| P30411 | B2 bradykinin receptor | Bradykinin receptor | C00001719 C00001724 C00011222 C00011230 | 0 / 0 |
| P32245 | Melanocortin receptor 4 | Melanocortin receptor | C00001719 C00001724 C00011222 C00011230 | 1 / 0 |
| P32238 | Cholecystokinin receptor type A | Cholecystokinin receptor | C00001719 C00001724 C00011222 C00011230 | 0 / 0 |
| P08311 | Cathepsin G | S1A | C00001719 C00001724 C00011222 C00011230 | 0 / 0 |
| Q99720 | Sigma non-opioid intracellular receptor 1 | Membrane receptor | C00001719 C00001724 C00011222 C00011230 | 1 / 0 |
| P03956 | Interstitial collagenase | M10A | C00001719 C00001724 C00011222 C00011230 | 0 / 1 |
| P32241 | Vasoactive intestinal polypeptide receptor 1 | Vasoactive intestinal peptide receptor | C00001719 C00001724 C00011222 C00011230 | 0 / 0 |
| P49146 | Neuropeptide Y receptor type 2 | Neuropeptide Y receptor | C00001719 C00001724 C00011222 C00011230 | 0 / 0 |
| Q16539 | Mitogen-activated protein kinase 14 | p38 | C00001719 C00001724 C00011222 C00011230 | 0 / 0 |
| P33765 | Adenosine receptor A3 | Adenosine receptor | C00001719 C00001724 C00011222 C00011230 | 0 / 0 |
| P05181 | Cytochrome P450 2E1 | Cytochrome P450 2E1 | C00001719 C00001724 C00011222 C00011230 | 0 / 0 |
| P04150 | Glucocorticoid receptor | NR3C1 | C00001719 C00001724 C00011222 C00011230 | 0 / 1 |
| P08172 | Muscarinic acetylcholine receptor M2 | Acetylcholine receptor | C00001719 C00001724 C00011222 C00011230 | 2 / 0 |
| P11229 | Muscarinic acetylcholine receptor M1 | Acetylcholine receptor | C00001719 C00001724 C00011222 C00011230 | 0 / 0 |
| P08246 | Neutrophil elastase | S1A | C00001719 C00001724 C00011222 C00011230 | 2 / 1 |
| P31645 | Sodium-dependent serotonin transporter | Serotonin | C00001719 C00001724 C00011222 C00011230 | 2 / 0 |
| P04626 | Receptor tyrosine-protein kinase erbB-2 | TK tyrosine-protein kinase EGFR subfamily | C00001719 C00001724 C00011222 C00011230 | 5 / 9 |
| P20309 | Muscarinic acetylcholine receptor M3 | Acetylcholine receptor | C00001719 C00001724 C00011222 C00011230 | 1 / 0 |
| P21452 | Substance-K receptor | Neurokinin receptor | C00001719 C00001724 C00011222 C00011230 | 0 / 0 |
| P51679 | C-C chemokine receptor type 4 | CC chemokine receptor | C00001719 C00001724 C00011222 C00011230 | 0 / 0 |
| P51681 | C-C chemokine receptor type 5 | CC chemokine receptor | C00001719 C00001724 C00011222 C00011230 | 3 / 0 |
| P50406 | 5-hydroxytryptamine receptor 6 | Serotonin receptor | C00001719 C00001724 C00011222 C00011230 | 0 / 0 |
| P06280 | Alpha-galactosidase A | Enzyme | C00001719 C00001720 C00011230 C00011232 | 1 / 1 |
| P41597 | C-C chemokine receptor type 2 | CC chemokine receptor | C00001719 C00001724 C00011222 C00011230 | 1 / 0 |
| P28482 | Mitogen-activated protein kinase 1 | Erk | C00001719 C00001724 C00011222 C00011230 | 0 / 0 |
| P08575 | Receptor-type tyrosine-protein phosphatase C | Enzyme | C00001719 C00001724 C00011222 C00011230 | 2 / 1 |
| Q12809 | Potassium voltage-gated channel subfamily H member 2 | KCNH, Kv10-12.x (Ether-a-go-go) | C00001719 C00001724 C00011222 C00011230 | 2 / 2 |
| P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | C00001719 C00001724 C00011222 C00011230 | 0 / 3 |
| Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 | Enzyme | C00001720 C00001724 C00011222 C00011232 | 1 / 1 |
| P21728 | D(1A) dopamine receptor | Dopamine receptor | C00001719 C00001724 C00011222 C00011230 | 0 / 0 |
| O76074 | cGMP-specific 3',5'-cyclic phosphodiesterase | PDE_5A | C00001719 C00001724 C00011222 C00011230 | 0 / 0 |
| P03372 | Estrogen receptor | NR3A1 | C00001719 C00001724 C00011222 C00011230 | 1 / 1 |
| P08588 | Beta-1 adrenergic receptor | Adrenergic receptor | C00001719 C00001724 C00011222 C00011230 | 1 / 0 |
| Q16637 | Survival motor neuron protein | Unclassified protein | C00001719 C00001720 C00011230 C00011232 | 4 / 1 |
| P28223 | 5-hydroxytryptamine receptor 2A | Serotonin receptor | C00001719 C00001724 C00011222 C00011230 | 0 / 0 |
| P28335 | 5-hydroxytryptamine receptor 2C | Serotonin receptor | C00001719 C00001724 C00011222 C00011230 | 0 / 0 |
| P35372 | Mu-type opioid receptor | Opioid receptor | C00001719 C00001724 C00011222 C00011230 | 0 / 0 |
| P08173 | Muscarinic acetylcholine receptor M4 | Acetylcholine receptor | C00001719 C00001724 C00011222 C00011230 | 0 / 0 |
| P25103 | Substance-P receptor | Neurokinin receptor | C00001719 C00001724 C00011222 C00011230 | 0 / 0 |
| P25105 | Platelet-activating factor receptor | PAF receptor | C00001719 C00001724 C00011222 C00011230 | 0 / 0 |
| P33032 | Melanocortin receptor 5 | Melanocortin receptor | C00001719 C00001724 C00011222 C00011230 | 0 / 0 |
| P21554 | Cannabinoid receptor 1 | Cannabinoid receptor | C00001719 C00001724 C00011222 C00011230 | 0 / 0 |
| P22303 | Acetylcholinesterase | Hydrolase | C00001719 C00001724 C00011222 C00011230 | 1 / 0 |
| P49798 | Regulator of G-protein signaling 4 | Unclassified protein | C00001719 C00001721 C00011230 | 2 / 0 |
| Q13526 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Enzyme | C00001719 C00001721 C00011230 | 0 / 0 |
| Q9UNA4 | DNA polymerase iota | Enzyme | C00001719 C00001721 C00011230 | 0 / 0 |
| Q6W5P4 | Neuropeptide S receptor | Neuropeptide receptor | C00001719 C00001721 C00011230 | 1 / 0 |
| Q9UIF8 | Bromodomain adjacent to zinc finger domain protein 2B | Unclassified protein | C00001719 C00001721 C00011230 | 0 / 0 |
| O94782 | Ubiquitin carboxyl-terminal hydrolase 1 | Enzyme | C00001721 C00001724 C00011222 | 0 / 0 |
| O75604 | Ubiquitin carboxyl-terminal hydrolase 2 | Enzyme | C00001719 C00001721 C00011230 | 0 / 0 |
| Q16236 | Nuclear factor erythroid 2-related factor 2 | Unclassified protein | C00001719 C00001721 C00011230 | 0 / 0 |
| P02545 | Prelamin-A/C | Unclassified protein | C00001719 C00001721 C00011230 | 11 / 10 |
| Q8IUX4 | DNA dC->dU-editing enzyme APOBEC-3F | Enzyme | C00001719 C00001721 C00011230 | 0 / 0 |
| Q92887 | Canalicular multispecific organic anion transporter 1 | Unclassified protein | C00001720 C00011232 | 1 / 1 |
| P28221 | 5-hydroxytryptamine receptor 1D | Serotonin receptor | C00001724 C00011222 | 0 / 0 |
| P47898 | 5-hydroxytryptamine receptor 5A | Serotonin receptor | C00001724 C00011222 | 0 / 0 |
| P04062 | Glucosylceramidase | Enzyme | C00001720 C00011232 | 6 / 4 |
| Q92830 | Histone acetyltransferase KAT2A | Enzyme | C00001724 C00011222 | 0 / 0 |
| P38398 | Breast cancer type 1 susceptibility protein | Enzyme | C00001724 C00011222 | 4 / 2 |
| O15245 | Solute carrier family 22 member 1 | Drug uniporter | C00001724 C00011222 | 0 / 0 |
| Q8N6T7 | NAD-dependent protein deacetylase sirtuin-6 | Enzyme | C00001724 C00011222 | 0 / 0 |
| P27338 | Amine oxidase [flavin-containing] B | Oxidoreductase | C00001724 C00011222 | 0 / 0 |
| P28222 | 5-hydroxytryptamine receptor 1B | Serotonin receptor | C00001724 C00011222 | 0 / 0 |
| P10253 | Lysosomal alpha-glucosidase | Hydrolase | C00001721 | 1 / 1 |
| P17405 | Sphingomyelin phosphodiesterase | Enzyme | C00001721 | 2 / 2 |
| P39748 | Flap endonuclease 1 | Enzyme | C00001721 | 0 / 0 |
| Q99700 | Ataxin-2 | Unclassified protein | C00001721 | 1 / 1 |
| O75164 | Lysine-specific demethylase 4A | Enzyme | C00001721 | 0 / 0 |
| Q99816 | Tumor susceptibility gene 101 protein | Unclassified protein | C00001721 | 0 / 0 |
2 Gene in CTD interactions
| gene | gene name | gene description | KNApSAcK metabolite in interactions |
|---|---|---|---|
| 836 | CASP3, CPP32, CPP32B, SCA-1 | caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) |
C00001720
C00001721
C00001723
C00001724
|
| 3357 | HTR2B, 5-HT(2B), 5-HT2B | 5-hydroxytryptamine (serotonin) receptor 2B, G protein-coupled |
C00001724
|
Related Diseases
Diseases related to proteins in ChEMBL interactions
OMIM (90)
| OMIM | preferred title | UniProt |
|---|---|---|
| #300438 | 17-beta-hydroxysteroid dehydrogenase x deficiency |
Q99714
|
| #100100 | Abdominal muscles, absence of, with urinary tract abnormality and cryptorchidism |
P20309
|
| #103780 | Alcohol dependence |
P08172
P14416 P31645 |
| #614373 | Amyotrophic lateral sclerosis 16, juvenile; als16 |
Q99720
|
| #608584 | Asthma-related traits, susceptibility to, 2 |
Q6W5P4
|
| #602025 | Body mass index quantitative trait locus 9; bmiq9 |
P41968
|
| #114480 | Breast cancer |
P38398
|
| #604370 | Breast-ovarian cancer, familial, susceptibility to, 1; brovca1 |
P38398
|
| #300615 | Brunner syndrome |
P21397
|
| #115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
| #212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
| #605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
| #162800 | Cyclic neutropenia |
P08246
|
| #612522 | Diabetes mellitus, insulin-dependent, 22; iddm22 |
P51681
|
| #119900 | Digital clubbing, isolated congenital |
P15428
|
| #609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
| #608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
| #237500 | Dubin-johnson syndrome; djs |
Q92887
|
| #181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
| #615363 | Estrogen resistance; estrr |
P03372
|
| #301500 | Fabry disease |
P06280
|
| #600274 | Frontotemporal dementia; ftd |
P10636
|
| #613659 | Gastric cancer |
P04626
|
| #137215 | Gastric cancer, hereditary diffuse; hdgc |
P04626
|
| #608013 | Gaucher disease, perinatal lethal |
P04062
|
| #230800 | Gaucher disease, type i |
P04062
|
| #230900 | Gaucher disease, type ii |
P04062
|
| #231000 | Gaucher disease, type iii |
P04062
|
| #231005 | Gaucher disease, type iiic |
P04062
|
| #231095 | Ghosal hematodiaphyseal dysplasia; ghdd |
P24557
|
| #137800 | Glioma susceptibility 1; glm1 |
P04626
|
| #232300 | Glycogen storage disease ii |
P10253
|
| #605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay |
Q03164
|
| #610140 | Heart-hand syndrome, slovenian type |
P02545
|
| #609423 | Human immunodeficiency virus type 1, susceptibility to |
P41597
P51681 |
| #176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
| #145000 | Hyperparathyroidism 1; hrpt1 |
O00255
|
| #259100 | Hypertrophic osteoarthropathy, primary, autosomal recessive, 1; phoar1 |
P15428
|
| #612244 | Inflammatory bowel disease 13; ibd13 |
P08183
|
| #603932 | Intervertebral disc disease; idd |
P14780
|
| #151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
| #613688 | Long qt syndrome 2; lqt2 |
Q12809
|
| #211980 | Lung cancer |
P00533
P04626 |
| #608516 | Major depressive disorder; mdd |
P08172
|
| #248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
| #300705 | Mental retardation, x-linked 17; mrx17 |
Q99714
|
| %300852 | Mental retardation, x-linked 88; mrx88 |
P50052
|
| #300220 | Mental retardation, x-linked, syndromic 10; mrxs10 |
Q99714
|
| #613073 | Metaphyseal anadysplasia 2; mandp2 |
P14780
|
| #131100 | Multiple endocrine neoplasia, type i; men1 |
O00255
|
| #126200 | Multiple sclerosis, susceptibility to; ms |
P08575
|
| #613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
| #159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
| #607948 | Mycobacterium tuberculosis, susceptibility to |
P11473
|
| #159900 | Myoclonic dystonia |
P14416
|
| #160900 | Myotonic dystrophy 1; dm1 |
Q9NR56
|
| #202700 | Neutropenia, severe congenital, 1, autosomal dominant; scn1 |
P08246
|
| #257200 | Niemann-pick disease, type a |
P17405
|
| #607616 | Niemann-pick disease, type b |
P17405
|
| #601665 | Obesity |
P32245
|
| #164230 | Obsessive-compulsive disorder; ocd |
P31645
|
| #604715 | Orthostatic intolerance |
P23975
|
| #259730 | Osteopetrosis, autosomal recessive 3; optb3 |
P00918
|
| #167000 | Ovarian cancer |
P04626
P38398 |
| #614320 | Pancreatic cancer, susceptibility to, 4; pnca4 |
P38398
|
| #168600 | Parkinson disease, late-onset; pd |
P04062
|
| #260540 | Parkinson-dementia syndrome |
P10636
|
| #613135 | Parkinsonism-dystonia, infantile; pkdys |
Q01959
|
| #172700 | Pick disease of brain |
P10636
|
| #601399 | Platelet disorder, familial, with associated myeloid malignancy |
Q01196
|
| #607276 | Resting heart rate, variation in |
P08588
|
| #275210 | Restrictive dermopathy, lethal |
P02545
|
| #604906 | Schizophrenia 9; sczd9 |
P49798
|
| #181500 | Schizophrenia; sczd |
P49798
|
| #608971 | Severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-positive |
P08575
|
| #609620 | Short qt syndrome 1; sqt1 |
Q12809
|
| #253300 | Spinal muscular atrophy, type i; sma1 |
Q16637
|
| #253550 | Spinal muscular atrophy, type ii; sma2 |
Q16637
|
| #253400 | Spinal muscular atrophy, type iii; sma3 |
Q16637
|
| #271150 | Spinal muscular atrophy, type iv; sma4 |
Q16637
|
| #183090 | Spinocerebellar ataxia 2; sca2 |
Q99700
|
| #607250 | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy; scan1 |
Q9NUW8
|
| #601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
| #188570 | Thyroid hormone resistance, generalized, autosomal dominant; grth |
P10828
|
| #274300 | Thyroid hormone resistance, generalized, autosomal recessive; grth |
P10828
|
| #145650 | Thyroid hormone resistance, selective pituitary; prth |
P10828
|
| #190300 | Tremor, hereditary essential, 1; etm1 |
P35462
|
| #277440 | Vitamin d-dependent rickets, type 2a; vddr2a |
P11473
|
| #610379 | West nile virus, susceptibility to |
P51681
|
| #112100 | Yt blood group antigen |
P22303
|
KEGG DISEASE (73)
| KEGG | name | UniProt |
|---|---|---|
| H00033 | Adrenal carcinoma |
O00255
(related)
|
| H00034 | Carcinoid |
O00255
(related)
|
| H00045 | Malignant islet cell carcinoma |
O00255
(related)
|
| H00246 | Primary hyperparathyroidism |
O00255
(related)
|
| H01102 | Pituitary adenomas |
O00255
(related)
|
| H00016 | Oral cancer |
P00533
(related)
P00533 (marker) |
| H00017 | Esophageal cancer |
P00533
(related)
P35354 (related) |
| H00018 | Gastric cancer |
P00533
(related)
P04626 (related) |
| H00022 | Bladder cancer |
P00533
(related)
P04626 (related) |
| H00028 | Choriocarcinoma |
P00533
(related)
P03956 (related) P04626 (related) |
| H00030 | Cervical cancer |
P00533
(related)
P04626 (related) |
| H00042 | Glioma |
P00533
(related)
P00533 (marker) |
| H00055 | Laryngeal cancer |
P00533
(related)
P00533 (marker) |
| H00241 | Combined proximal and distal renal tubular acidosis (RTA type 3) |
P00918
(related)
|
| H00436 | Osteopetrosis |
P00918
(related)
|
| H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
|
| H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
| H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
|
| H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
| H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
| H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
| H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
| H00663 | Restrictive dermopathy |
P02545
(related)
|
| H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
| H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
| H00026 | Endometrial Cancer |
P03372
(marker)
P04626 (related) Q92731 (marker) |
| H00066 | Lewy body dementia (LBD) |
P04062
(related)
|
| H00126 | Gaucher disease |
P04062
(related)
|
| H00426 | Defects in the degradation of ganglioside |
P04062
(related)
|
| H00810 | Progressive myoclonic epilepsy (PME) |
P04062
(related)
|
| H00599 | 46,XX disorders of sex development (Disorders related to androgen excess) |
P04150
(related)
|
| H00019 | Pancreatic cancer |
P04626
(related)
|
| H00027 | Ovarian cancer |
P04626
(related)
P38398 (related) |
| H00031 | Breast cancer |
P04626
(related)
P04626 (marker) P38398 (related) |
| H00046 | Cholangiocarcinoma |
P04626
(related)
P35354 (related) |
| H00093 | Combined immunodeficiencies (CIDs) |
P06239
(related)
|
| H00125 | Fabry disease |
P06280
(related)
|
| H00079 | Asthma |
P07550
(related)
|
| H00100 | Neutropenic disorders |
P08246
(related)
|
| H00091 | T-B+Severe combined immunodeficiencies (SCIDs) |
P08575
(related)
|
| H00036 | Osteosarcoma |
P08684
(marker)
|
| H00069 | Glycogen storage diseases (GSD) |
P10253
(related)
|
| H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
|
| H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
| H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
| H00249 | Thyroid hormone resistance syndrome |
P10828
(related)
|
| H00342 | Tuberculosis |
P11473
(related)
|
| H00784 | Localized autosomal recessive hypotrichosis |
P11473
(related)
|
| H01143 | Vitamin D-dependent rickets |
P11473
(related)
|
| H01205 | Coumarin resistance |
P11712
(related)
|
| H00025 | Penile cancer |
P14780
(related)
P35354 (related) |
| H00479 | Metaphyseal dysplasias |
P14780
(related)
|
| H00457 | Primary hypertrophic osteoarthropathy (PHO) |
P15428
(related)
|
| H01246 | Isolated congenital nail clubbing (ICNC) |
P15428
(related)
|
| H00137 | Niemann-Pick disease (NPD) typeA and B |
P17405
(related)
|
| H00424 | Defects in the degradation of sphingomyelin |
P17405
(related)
|
| H00548 | Brunner syndrome |
P21397
(related)
|
| H01031 | Orthostatic intolerance (OI) |
P23975
(related)
|
| H00490 | Diaphyseal dysplasia with anemia (Ghosal) |
P24557
(related)
|
| H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
| H00480 | Non-syndromic X-linked mental retardation |
P50052
(related)
Q99714 (related) |
| H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q01196
(related)
Q01196 (marker) Q03164 (related) Q03164 (marker) |
| H00003 | Acute myeloid leukemia (AML) |
Q01196
(related)
Q01196 (marker) Q13951 (marker) |
| H00004 | Chronic myeloid leukemia (CML) |
Q01196
(related)
|
| H00978 | Thrombocytopenia (THC) |
Q01196
(related)
|
| H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) |
Q03164
(related)
|
| H00720 | Long QT syndrome |
Q12809
(related)
|
| H00725 | Short QT syndrome |
Q12809
(related)
|
| H00455 | Spinal muscular atrophy (SMA) |
Q16637
(related)
|
| H00208 | Hyperbilirubinemia |
Q92887
(related)
|
| H00063 | Spinocerebellar ataxia (SCA) |
Q99700
(related)
Q9NUW8 (related) |
| H00658 | Syndromic X-linked mental retardation |
Q99714
(related)
|
| H00925 | 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency |
Q99714
(related)
|
Diseases related to CTD interactions
73 disease in interactions with metabolites
| MESH or OMIM | name |
KNApSAcK
metabolite |
|---|---|---|
| D054058 | Acute Coronary Syndrome |
C00001724
|
| D020236 | Amnesia, Transient Global |
C00001724
|
| D000787 | Angina Pectoris |
C00001724
|
| D000788 | Angina Pectoris, Variant |
C00001724
|
| D001157 | Arterial Occlusive Diseases |
C00001724
|
| D001929 | Brain Edema |
C00001724
|
| D020520 | Brain Infarction |
C00001724
|
| D002340 | Carotid Artery Diseases |
C00001724
|
| D002341 | Carotid Artery Thrombosis |
C00001724
|
| D002539 | Cerebral Arterial Diseases |
C00001724
|
| D002544 | Cerebral Infarction |
C00001724
|
| D002637 | Chest Pain |
C00001724
|
| D003027 | Cluster Headache |
C00001724
|
| D003324 | Coronary Artery Disease |
C00001724
|
| D003327 | Coronary Disease |
C00001724
|
| D054059 | Coronary Occlusion |
C00001724
|
| D023921 | Coronary Stenosis |
C00001724
|
| D003328 | Coronary Thrombosis |
C00001724
|
| D003329 | Coronary Vasospasm |
C00001724
|
| D003680 | Deglutition Disorders |
C00001724
|
| D003967 | Diarrhea |
C00001724
|
| D004421 | Dystonia |
C00001724
|
| D004881 | Ergotism |
C00001724
|
| D005130 | Eye Hemorrhage |
C00001724
|
| D005316 | Fetal Distress |
C00001724
|
| D005355 | Fibrosis |
C00001724
|
| D005734 | Gangrene |
C00001724
|
| D013700 | Giant Cell Arteritis |
C00001724
|
| D006261 | Headache |
C00001724
|
| D051270 | Headache Disorders, Primary |
C00001724
|
| D006331 | Heart Diseases |
C00001724
|
| D006349 | Heart Valve Diseases |
C00001724
|
| D006685 | Hoarseness |
C00001724
|
| D006732 | Horner Syndrome |
C00001724
|
| D006940 | Hyperemia |
C00001724
|
| D007024 | Hypotension, Orthostatic |
C00001724
|
| D007035 | Hypothermia |
C00001724
|
| D007238 | Infarction |
C00001724
|
| D007383 | Intermittent Claudication |
C00001724
|
| D020300 | Intracranial Hemorrhages |
C00001724
|
| D007511 | Ischemia |
C00001724
|
| D002546 | Ischemic Attack, Transient |
C00001724
|
| D001523 | Mental Disorders |
C00001724
|
| D008881 | Migraine Disorders |
C00001724
|
| D009072 | Moyamoya Disease |
C00001724
|
| D054084 | Myocardial Bridging |
C00001724
|
| D009203 | Myocardial Infarction |
C00001724
|
| D017202 | Myocardial Ischemia |
C00001724
|
| D009325 | Nausea |
C00001724
|
| D009395 | Nephritis, Interstitial |
C00001724
|
| D009896 | Optic Atrophy |
C00001724
|
| D018917 | Optic Neuropathy, Ischemic |
C00001724
|
| D010167 | Pallor |
C00001724
|
| D010211 | Papilledema |
C00001724
|
| D010292 | Paresthesia |
C00001724
|
| D010523 | Peripheral Nervous System Diseases |
C00001724
|
| D016491 | Peripheral Vascular Diseases |
C00001724
|
| D012003 | Rectal Fistula |
C00001724
|
| D012021 | Reflex, Abnormal |
C00001724
|
| D012019 | Reflex Sympathetic Dystrophy |
C00001724
|
| D012640 | Seizures |
C00001724
|
| D020886 | Somatosensory Disorders |
C00001724
|
| D013035 | Spasm |
C00001724
|
| D019966 | Substance-Related Disorders |
C00001724
|
| D013375 | Substance Withdrawal Syndrome |
C00001724
|
| D013971 | THYROTOXICOSIS |
C00001724
|
| D014060 | Tongue Diseases |
C00001724
|
| D014652 | Vascular Diseases |
C00001724
|
| D020246 | VENOUS THROMBOSIS |
C00001724
|
| D014693 | Ventricular Fibrillation |
C00001724
|
| D014717 | Vertigo |
C00001724
|
| D014839 | Vomiting |
C00001724
|
| D014987 | Xerostomia |
C00001724
|